Comparison

Infliximab European Partner

Item no. TMO-T9921-100mg
Manufacturer TargetMol
CASRN 170277-31-3
Amount 100mg
Quantity options 100mg 10mg 1 mg 25 mg 2 mg 50mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 0,98
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping condition Cool pack
Available
Manufacturer - Targets
TNF
TNF
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
149 kDa
Description
Infliximab is a monoclonal antibody, a human-mouse chimeric monoclonal antibody that inhibits TNF-α and prevents TNF-α from interacting with TNFR1 and TNFR2. Infliximab can be used to treat Crohn's disease and rheumatoid arthritis.
Pathways
Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Delivery expected until 1/31/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close